Skip to main content
Optimi Health Corp. logo

Optimi Health Corp. — Investor Relations & Filings

Ticker · OPTI ISIN · CA68405H1001 LEI · 98450063FDFF8UD3Q652 CSE Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2024-03-26 Regulatory Filings
Country CA Canada
Listing CSE OPTI

About Optimi Health Corp.

https://www.optimihealth.ca/

Optimi Health Corp. is a GMP-certified pharmaceutical drug manufacturer and end-to-end drug researcher licensed to produce and supply controlled psychedelic substances. The company specializes in the production of MDMA and psilocybin, primarily supporting psychedelic-based mental health treatments. Additionally, Optimi operates a vertically integrated functional mushroom brand, developing scalable, natural mushroom formulations aimed at the health and wellness sector. This structure allows the company to serve both regulated pharmaceutical supply chains and consumer wellness markets.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2024-03-26 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2024-03-01 English
Interim MD&A - English.pdf
Regulatory Filings
2024-03-01 English
Interim financial statements/report – English.pdf
Regulatory Filings
2024-03-01 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed information about securities distribution, including issuer details, distribution dates, purchaser information, compensation related to the distribution, and regulatory compliance data. It is a regulatory filing form used in Canadian securities regulation to report exempt distributions of securities. The content is not a financial report, earnings release, or management discussion but a specific regulatory compliance report related to securities distribution. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory documents that do not fit other specific categories.
2024-02-28 English
Material change report - English.pdf
Regulatory Filings Classification · 100% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and details a material change event dated February 23, 2024, involving the closing of the first tranche of a non-brokered private placement. It includes specifics about the securities issued, insider participation, and related party transactions. The document is a regulatory filing under Canadian securities legislation, specifically a Material Change Report, which is a disclosure document for significant corporate events but not a financial report or earnings release. It is not an announcement of a report publication but a standalone regulatory disclosure. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-02-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.